June 2017
MedEarly Healtqhcare are pleased to announce an exclusive distribution agreement with Mecellis, an innovative and rapidly growing Biological Acellular Dermal Matrix manufacturing and marketing company.
Mecellis Biotech is a leading innovative company in the area of Tissue and Cell Engineering. The company focusses on the needs of patients, engaged in the research, development, manufacture and marketing of innovative technologies, with a diversified offer for multiple surgical specialties.
After 5 years of marketing, Meccellis Biotech is now present in 25 countries in Europe, Africa and the Middle East. The passion and professionalism of its teams have made Meccellis Biotech, a reference company in biomaterials.
The partnership with Mecellis enables MedEarly Healthcare to progress our mission of providing innovative medical technology to Irish carers and patients in a cost effective manner. Mecellis biological implants are used across a surgical disciplines such as ENT, General, Colorectal, Gynaecological, vascular and urology. wounds.
April 2017
The Irish Tissue Viability Nurse Association bi- annual working group meeting was held March 30th at the Kilmainham Hilton Hotel, Dublin.
MedEarly Healthcare Ltd and Synapse Electroceutical technology were proud sponsors of the meeting and hosted a dedicated session on the role of electroceutical technolology in the management of complex wounds. The presentation was given by Liz Ovens, an independent Tissue Viability Nurse and associate lecturer, Bucks New University UK.
Liz discussed the challenging complexities in managing venous leg ulcers (VLU’s) including the varying treatment modalities and in particular the role and associated treatment with electroceutical technology. She spoke from her personal experience as a practitioner of the significant clinical benefit and improvement in quality of life for VLU patients treated with electroceutical technology.
The Irish experience of VLU patients treated with this technology was presented by the group and stimulated much discussion and interest in this subject.
John Gildersleeve, CEO Synapse Electroceutical Technology spoke of the journey from “curiosity to credibility” outlining the stages from concept to design to market for Accel-Heal®, a unique electroceutical treatment for complex wounds.
March 2017
MedEarly Healthcare are pleased to announce signing of an exclusive distribution contract with BAP Medical for the Irish market. BAP Medical are a perfect fit for MedEarly Healthcare and this partnership will offer Irish carers and patients new solutions for varying skin conditions and burns management.
About BAP Medical
BAP Medical provides solutions for skin ‘in distress’. Since 2006 BAP Medical has provided products for the aftercare of specific skin problems:
- Aftercare for burns
- Scar formation on deep wounds
- Aftercare following radiation therapy
- Skin complaints caused by eczema and other chronic skin disorders
- House dust mite allergy complaints
Scientifically proven effectiveness
Our products are developed in conjunction with patients and with those providing treatment. In doing so, we set ourselves 2 strict requirements:
- Our products must be truly effective.
- Our products’ effectiveness must be scientifically proven.
In short, we believe that our products must deliver added value – to both patients and doctors. Which is why BAP stands for the ‘Best Available Practices’ (in healthcare).
Active worldwide
Our products are distributed in more than 40 countries around the world, with those in Europe, the Middle East and Asia being our biggest customers. Our ambition is unrelenting and we continue to work hard to extend our export network.
We have our own sales organisations in the Netherlands and Belgium. Our head office is located in Apeldoorn, in the Netherlands.
BAP Medical is ISO 13485 certified by KIWA / CERMET. According to the European directive 93/42/EEC on medical devices, the products of BAP Medical are classified as medical device class I.
Mission
Our mission is to develop, produce and market ‘Best Available Practices’ which meet the needs of our markets, both at home (in the Benelux) and worldwide. Our market is defined as people with ‘skin in distress’. We strive to ensure that our products will always deliver added value to our clients. Whether these are patients, prescribers or pharmacies – and wherever they are in the world.
Vision
We strive to produce relevant and innovative products for patients with special skin care needs (‘skin in distress’) on a global basis. The effectiveness of our products is scientifically proven.
February 2017
MedEarly Healthcare are pleased to announce our partnership with Hibernia Medical Ireland ( www.hiberniamedical.ie)
Hibernia Medical are an established medical device supplier to the Irish healthcare market and will act as logistics partner to MedEarly Healthcare.
July 2016
MedEarly Healthcare signed an exclusive agreement with Synapse Electroceutical Ltd to distribute Accel-Heal®, an externally applied electroceutical for the treatment of complex wounds. Synapse Electroceutical are pioneering exciting new science in the rapidly developing field of electroceutical medicine. Synapse and MedEarly Healthcare bring Accel-Heal® to the Irish market Autumn 2016.